This study is a non-interventional prospective, multicenter, longitudinal study conducted in France, among a representative sample of public and/or private birth control centers. The aim of the study is to assess, in real-life settings, the success rate of the protocol Mifegyne / prostaglandin analogue in patients asking for medical abortion either prior or beyond 7 weeks of amenorrhea.
Study Type
OBSERVATIONAL
Enrollment
892
Hôpital de la Conception
Marseille, France
success rate of the protocol Mifegyne and prostaglandin analogue
The success rate will be defined as complete abortion without surgical procedure
Time frame: At the follow-up at 2-3 weeks after inclusion
Success rate of the protocol Mifegyne and misoprostol per os.
The success rate will be defined as complete abortion without surgical procedure
Time frame: at the follow up at 2-3 weeks after the inclusion
rate of ongoing pregnancy by term.
Time frame: at the follow up at 2-3 weeks after the inclusion
rate of patients requiring any additional procedures by term.
Time frame: at the follow up at 2-3 weeks after the inclusion
Number of medical abortion using misoprostol
The number of medical abortion using misoprostol will be described.
Time frame: at the follow up at 2-3 weeks after the inclusion
Evaluation by patients of pain using a 5 level verbal rating scale
Physician will ask patients to evaluate the pain by a 5 level verbal rating scale. the using of pain killers will be also described
Time frame: at the follow up at 2-3 weeks after the inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.